Serine protease inhibitors inhibit superoxide production by human polymorphonuclear leukocytes and monocytes stimulated by various surface active agents.
D000001:Calcimycin / Q000494:pharmacology; D002118:Calcium / Q000494:pharmacology; D006801:Humans; D007700:Kinetics; D009000:Monocytes / Q000187:drug effects / Q000378:metabolism*; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D010100:Oxygen / Q000097:blood*; D011480:Protease Inhibitors / Q000097:blood*; D012694:Serine; D013481:Superoxides / Q000097:blood*; D013501:Surface-Active Agents / Q000494:pharmacology*
D011480:Protease Inhibitors; D013501:Surface-Active Agents; D013481:Superoxides; D000001:Calcimycin; D012694:Serine; D010100:Oxygen; D002118:Calcium